Machine Learning

A new partnership combines radiation-free imaging with advanced AI analytics, aiming to revolutionize breast cancer detection and patient care.

With the appointment of Kelly Johnston McKee, Science 37 signals a major push to redefine patient experience and operationalize the future of clinical research.

Canadian giant Mackenzie Investments partners with SEI, leveraging the booming CIT market to bring its data-driven equity strategies to U.S. institutions.

A new platform promises to solve the persistent challenges of trading system development, freeing firms from infrastructure burdens to focus on innovation.

Over half of Canadians suspect they've applied for fake jobs. As mental health suffers, Ontario's new laws aim to force transparency. Will it work?

An oral drug for Huntington's disease shows early success, improving patient scores where a decline was expected, fueling hope for a breakthrough treatment.

A major price drop on high-quality synthetic DNA from Elegen is set to democratize research, accelerate innovation, and disrupt the biotech market.

CI Global Asset Management launches innovative funds combining crypto's growth and gold's stability, challenging traditional diversification with a 0% fee offer.

A pivotal FDA meeting moves a novel drug forward for Dementia with Lewy Bodies, a disease with no approved therapies, offering new hope to patients.

Amid market chaos, firms are ditching manual pricing. See how Zilliant's new AI is helping businesses like Julius Hoesch turn volatility into profit.

A new drug targeting a genetic form of Parkinson's shows promise as its late-stage trial nears completion, offering hope for a precision treatment.

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

Veteran leader Emma Rooth takes charge at PCCA UK, bringing a track record of transformation to the booming personalized medicine market.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

A new 4,000 sqm facility is solving robotics' biggest problem: teaching AI how to navigate the real world by generating the one thing it lacks—experience.

3Shape appoints Coloplast's Rasmus Hannemann as SVP, a strategic move signaling a major push to accelerate growth in the competitive digital dentistry market.

A new open-source AI from Ant Group's Robbyant finally lets robots see through glass and mirrors, a breakthrough poised to reshape the robotics industry.

LuskinOIC honors a pioneer of artificial joints with a new award, celebrating a legacy of innovation and propelling the next wave of orthopaedic discovery.